Original ResearchA Boosted Ensemble Algorithm for Determination of Plaque Stability in High-Risk Patients on Coronary CTA
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
This trial was supported by National Institutes of Health Grant No. HL115150 (to Dr. Min) and the Leading Foreign Research Institute Recruitment Program of the National Research Foundation of Korea, Ministry of Science, ICT and Future Planning (Seoul, Korea). The research reported in this manuscript was also supported, in part by, the Dalio Institute of Cardiovascular Imaging (New York, New York). Dr. Signh is an employee of GlaxoSmithKline. Dr. Bax has received speaker fees from Abbott Vascular; and received institutional research grant support from Abbott Vascular, Edwards Lifesciences, Biotronik, Bioventrix, Boston Scientific, Medtronic, and GE Healthcare. Dr. Chinnaiyan has received institutional research grant support and served as a consultant for HeartFlow. Dr. Chow is the Saul and Edna Goldfarb Chair in Cardiac Imaging Research; and has received research grant support from TD Bank, CV Diagnostics and AusculSciences, Siemens Healthineers, and TeraRecon; and owns equity in GE Healthcare. Dr. Cury has served as a consultant for GE Healthcare, Cleerly Health, and Spreemo Health. Dr. Leipsic has served as a consultant for and owns stock options in HeartFlow and Circle CVI; and received research grant support from and served on the Speakers Bureau for GE Healthcare. Dr. Pontone has a research grant and/or honorarium as a speaker from GE Healthcare, Bracco, Bayer, Medtronic, and HeartFlow. Dr. Berman has received research grant support from HeartFlow and software royalties from Cedars-Sinai Medical Center. Dr. Budoff received research grant support from the National Institutes of Health and GE Healthcare. Dr. Samady has served as a consultant and received research grant support from Philips; has received institutional research grant support from Abbott Vascular, Medtronic, and Philips; is co-founder of Covanos; and owns equity in Covanos and SIG. Dr. Shaw owns equity in Cleerly Health. Dr. Min has received funding from the Dalio Foundation, the National Institutes of Health, and GE Healthcare; has served on the scientific advisory board of Arineta and GE Healthcare; and previously worked at Weill Cornell Medicine but is now an employee of and owns equity in Cleerly Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Harvey Hecht, MD, was Guest Editor on this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.